Europe Dental Bone Graft Substitutes Market worth USD 641.46 million by 2031
The report "Europe Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft,Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, And Country" is projected to reach USD 641.46 million by 2031 from USD 411.07 million in 2025, at a CAGR of 6.4% during the forecast period.
Browse 300 market data Tables and 65 Figures spread through 360 Pages and in-depth TOC on "Europe Dental Bone Graft Substitutes Market, By Type (Xenograft, Allograft,Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, And Country"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-dental-bone-graft-substitutes-market-218770889.html
The?????? European market for dental bone graft substitutes is influenced by the following factors: innovations in regenerative biomaterials, improved clinical outcomes, cost-efficient treatment strategies, and the increasing awareness of bone regeneration procedures among dental professionals. Long-term market prospects remain vibrant, mainly supported by Europe's aging population, which accounted for more than 21.6% of people aged 65 years and above as of January 2024 (Eurostat). The change in the age structure is closely related to the increased prevalence of tooth loss and periodontal disease, which, in turn, increases the demand for bone augmentation procedures as a prerequisite for implant placement. The improvements in synthetic and bioactive bone graft materials, along with better handling characteristics and predictable resorption profiles, are making the procedures more efficient and clinically reliable. Aided by the growing use of implant-based restorative dentistry, these factors are driving the wider acceptance and sustained growth of dental bone graft substitutes in Europe.
The hospital end user segment of the Europe dental bone graft substitutes market is expected to grow at the highest CAGR during the forecast period.
The hospital segment is forecasted to grow at the highest CAGR from 2026 to 2031. Bone grafting is frequently used in hospitals for oral and maxillofacial surgery, including procedures such as jaw reconstruction, alveolar ridge preservation, cleft lip and palate repair, and dental implantology. When natural jawbone is insufficient for implant placement, bone grafts provide a foundation for successful implant osseointegration (fusion with bone).
The bio OSS segment is expected to account for the largest share, by product, in the Europe dental bone graft substitutes market.
By product, the Europe dental bone graft substitute market is segmented into bio OSS, osteograf, grafton, and others. Bio-OSS accounts for the largest share in the product category. Bio-OSS has a long history of successful use in dental bone grafting procedures, with extensive clinical research supporting its efficacy and safety, which is expected to drive the segment growth.
The osteoconduction segment is expected to account for the largest share, by mechanism, in the Europe dental bone graft substitutes market.
The Europe dental bone graft substitutes market is segmented based on mechanism into bio osteoconduction, osteoinduction, osteopromotion, and osteogenesis. Osteoconduction accounts for the largest share in the mechanism category. Osteoconduction promotes bone regeneration at the defect site, provides a foundation for dental implant placement, supports jawbone structure, and prevents collapse, which is expected to drive the segment growth.
Germany accounted for the largest market share in the Europe dental bone graft substitutes market in 2025.
Europe Dental bone graft substitutes market is segmented into five major countries, namely, France, Germany, UK, Spain, Italy, and Rest of Europe.
Germany?????? is the biggest market for dental bone graft substitutes in Europe. The main reasons behind this are the rapidly aging population and high implant-based dental care adoption. Based on information from the UN Population Division, Germany is on its way to become a super-aged society. The population aged 65 and above is forecasted to grow by 41% to around 24 million by 2050, which will make up almost one-third of the total population. At the same time, the population of the working age (15–64 years) is anticipated to fall drastically, thus the problem of age-related oral health issues like tooth loss and periodontal bone degeneration will become even more serious. As a result of this demographic change, there is a continuous increase in the number of dental implant surgeries and the corresponding bone augmentation and regeneration treatments. Therefore, there is a strong and stable demand for dental bone graft substitutes throughout the ??????country.
Key Players
The prominent players in the Europe dental bone graft substitutes market include Institut Straumann AG (Switzerland), Dentsply Sirona (US), Envista (US), Kuraray Co. Ltd. (Japan), Johnson & Johnson (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Zimvie Inc. (US), Henry Schein Inc. (US), and Integra Lifesciences Holdings Corporation (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Dental Bone Graft Substitutes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
